$PRLB

WEHRWEIN SVEN sold $39K of PRLB

WEHRWEIN SVEN sold 500 shares of Proto Labs Inc (PRLB) at $78.38 on 2026-06-02.

Original reporting
SEC EDGAR · WEHRWEIN SVEN
Published Jun 4, 2026, 8:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PRLB
Neutral
medium confidence
Mentioned
$PRLB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRLBNeutralLow
01

Why it matters

The disclosure updates the insider-trading record with a specific open-market sale price and post-transaction holdings, which can marginally influence sentiment but is not a standalone fundamental event.

02

Market read

Traders may use the sale as a sentiment datapoint, but without additional company-specific catalysts it is unlikely to materially change valuation expectations.

03

What to watch

Transaction size (500 shares) and lack of a 10b5-1 plan context can reduce interpretability; compare with prior insider activity and any concurrent company news.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-04; sale executed 2026-06-02.

Background

The article is an SEC Form 4 insider transaction disclosure for Proto Labs (PRLB).

Company-level read

Ticker impact

$PRLBNeutralMedium confidence
Context

Proto Labs director WEHRWEIN SVEN sold 500 shares in an open-market transaction at $78.38 on 2026-06-02, disclosed via Form 4.

Expected impact

Likely limited near-term impact; watch for follow-on insider activity or other catalysts.

Evidence & confidence

The filing provides a specific sale price/date and size, but insider transactions alone rarely drive sustained repricing without corroborating news.

Market effects

No clear sector read-through from a single director’s small sale.

None.

None.

Counterpoint

A non-10b5-1 sale can be driven by diversification/tax needs rather than bearish expectations, so the signal may be overstated.

Key entities

  • Proto Labs Inc

    Subject of the Form 4 insider transaction disclosure.

  • WEHRWEIN SVEN

    Director who sold 500 shares of PRLB.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PRLBMed

Is Proto Labs (PRLB) Fully Valued As A New COO Reshapes Operations?

Proto Labs (PRLB) appointed Sam Ramahi as Chief Operations Officer, focusing on operational leadership and global supply chain management. The stock has seen a 12-month total shareholder return of 60.09% and a year-to-date return of 55.29%, closing at $79.74. Analysts debate whether the current price reflects its shift, with a fair value estimate of $95.50, citing strong cash generation and growth potential. However, risks include customer concentration and weakness in Europe, and the stock trad

$PRLBLow

Protolabs Names Sam Ramahi COO to Lead Global Manufacturing Operations

Protolabs (PRLB) appointed Sam Ramahi as COO to lead global operations. Ramahi, with 25 years of experience, will oversee supply chain, quality, and continuous improvement. He previously led operations at SIG Group and Jacuzzi. The move supports Protolabs' strategy to expand from prototyping to production, aiming to improve performance and create value for shareholders.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.